
    
      Primary Objective: Evaluate the feasibility and safety of Creon in the treatment of post-RYGB
      hypoglycemia as add-on therapy to a diet higher in protein and lower in carbohydrate.

      Secondary Objective: Evaluate utility of continuous glucose monitoring (CGM) in monitoring
      hypoglycemia as an adjunct to standard venous blood testing using a glucometer in post-RYGB
      hypoglycemia.
    
  